Outpatient management of croup

Current Opinion in Pediatrics

Volumn 8, Issue 5, 1996, Pages 449-452

  Klassen, Terry P ^a   Rowe, Peter C ^b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BUDESONIDE; DEXAMETHASONE; GLUCOCORTICOID; PLACEBO; SODIUM CHLORIDE;

CLINICAL TRIAL; CORTICOSTEROID THERAPY; CROUP; DRUG EFFICACY; EMERGENCY WARD; HOSPITALIZATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; NEBULIZATION; ORAL DRUG ADMINISTRATION; OUTPATIENT CARE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0029959695     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199610000-00005     Document Type: Review

References (23)

1. Henrickson KJ, Kuhn SM, Savatski LL: Epidemiology and cost of infection with human parainfluenza virus types 1 and 2 in young children. Clin Infect Dis 1994, 18:770-779.
2. Denny FW, Murphy TF, Clyde WA, Collier AM, Henderson FW: Croup: an 11 year study in pediatric practice. Pediatrics 1983, 71:871-876.
3. Bank DE, Krug SE: New approaches to upper airway disease. Emerg Med Clin North Am 1995, 13:473-487.
4. Cressman WR, Myer CM: Diagnosis and management of croup and epiglottitis. Pediatr Clin North Am 1994, 41:265-276.
5. Rowe PC, Klassen TP: Corticosteroids for croup: reconciling town and gown. Arch Pediatr Adolesc Med 1996, 150:344-346.
6. Connors K, Gavula D, Terndrup T: The use of corticosteroids in croup: a survey. Pediatr Emerg Care 1994, 10:197-199.
7. Johansson SA, Andersson KE, Brattsand R, Gruvstad E, Hedner P: Topical and systemic glucocorticoid potencies of budesonide and beclomethasone in man. Eur J Clin Pharmacol 1982, 22:523-529.
8. Newhouse MT, Dolovich MB: Control of asthma by aerosols. N Engl J Med 1986, 315:870-874.
9. Klassen TP, Feldman ME, Watters LK, Sutcliffe T, Rowe PC: Nebulized budesonide for children with mild-to-moderate croup. N Engl J Med 1994, 331:285-289.
10. Klassen TP, Watters LK, Feldman ME, Sutcliffe T, Rowe PC: The efficacy of nebulized budesonide in dexamethasone-treated outpatients with croup. Pediatrics 1996, 97:463-466. This randomized, controlled trial demonstrated a significantly greater benefit to patients receiving nebulized budesonide and oral dexamethasone as compared to patients receiving oral dexamethasone alone.
11. Cruz MN, Stewart G, Rosenberg N: Use of dexamethasone in the outpatient management of acute laryngotracheitis. Pediatrics 1995, 96:220-223. In this study, patients were randomized to intramuscular dexamethasone or intramuscular placebo. Patients who received intramuscular dexamethasone had a slightly better outcome than those who received placebo.
12. Johnson DW, Schuh S, Koren G, Jaffe DM: Outpatient treatment of croup with nebulized dexamethasone. Arch Pediatr Adolesc Med 1996, 150:349-355. Patients were randomized to either nebulized dexamethasone or placebo in this clinical trial. Patients receiving dexamethasone had a faster resolution of symptoms but two patients (who were also noted to be neutropenic at the time) in this group developed bacterial tracheitis.
13. Geelhoed GC, Macdonald WBG: Oral and inhaled steroids in croup: a randomized, placebo-controlled trial. Pediatr Pulmonol 1995, 20:355-361. In this randomized, controlled trial, nebulized budesonide or oral dexamethasone had a similar benefit to patients, but both were superior to placebo.
14. Kairys SW, Olmstead EM, O'Connor GT: Steroid treatment of laryngotracheitis: a meta-analysis of the evidence from randomized trials. Pediatrics 1989, 83:683-693.
15. Skowron PN, Turner JA, McNaughton GA: The use of corticosteroid (dexamethasone) in the treatment of acute laryngotracheitis. Can Med Assoc J 1966, 94:528-531.
16. James JA: Dexamethasone in croup. Am J Dis Child 1969, 117:511-516.
17. Muhlendahl KE, Kahn D, Spohr HL, Dressler F: Steroid treatment in pseudo-croup. Helv Paediatr Acta 1982, 37:431-436.
18. Geelhoed GC, Macdonald WBG: Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3 mg/kg versus 0.6 mg/kg. Pediatr Pulmonol 1995, 20:362-368. Patients randomized to any of the doses of oral dexamethasone (0.15 mg/kg or 0.30 mg/kg or 0.6 mg/kg) had a similar outcome in this randomized, controlled trial.
19. Kristjansson S, Berg Kelly K, Winso E: Inhalation of racemic adrenaline in the treatment of mild and moderately severe croup: clinical symptom score and oxygen saturation measurements for evaluation of treatment effects. Acta Paediatr 1994, 83:1156-1160.
20. Ledwith CA, Shea LM, Mauro RD: Safety and efficacy of nebulized racemic epinephrine in conjunction with oral dexamethasone and mist in the outpatient treatment of croup. Ann Emerg Med 1995, 25:331-337.
21. Prendergast M, Jones JS, Hartman D: Racemic epinephrine in the treatment of laryngotracheitis: can we identify children for outpatient therapy? Am J Emerg Med 1994, 12:613-616.
22. Kelley PB, Simon JE: Racemic epinephrine use in croup and disposition. Am J Emerg Med 1992, 10:181-183.
23. Waiisman Y, Klein BL, Boenning DA, Young GM, Chamberlain JM, O'Donnell R, Oschenschlager DW: Prospective randomized double-blind study comparing L-epinephrine and racemic epinephrine aerosols in the treatment of laryngotracheitis (croup). Pediatrics 1992, 89:302-306.